--------------------------------------------------------------------------------

Exhibit 10.15
 
EMPLOYMENT AGREEMENT
 
EMPLOYMENT AGREEMENT (this "Agreement") dated as of July 22, 2013, between
Uroplasty, Inc., a Minnesota corporation (the "Company"), and Robert C. Kill, a
resident of the State of Minnesota (the "Executive").
 
WHEREAS, the Company is a medical device company that develops, manufactures and
markets innovative, proprietary products for the treatment of voiding
dysfunctions;
 
WHEREAS, the Executive has been a member of the Board of Directors of the
Company since December 2010 and is currently serving as Interim Chief Executive
Officer;
 
WHEREAS, the Company and the Executive desire to set forth in this Agreement the
terms under which Executive will serve as President and Chief Executive Officer
of the Company.
 
NOW, THEREFORE, in consideration of the premises, the mutual agreements set
forth below and other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the parties agree as follows:
 
1.    Employment.  The Company hereby agrees to employ the Executive, and the
Executive hereby accepts the Company's offer to serve, as President and Chief
Executive Officer of the Company effective immediately after filing of the
Company's annual report on Form 10-K for the year ended March 31, 2013 (the
"Start Date").  The Executive shall have the responsibilities, duties and
authority reasonably afforded to and expected of the President and Chief
Executive Officer and will report directly to the Company's Board of Directors.
The Executive agrees to devote the Executive's full business time, attention and
efforts to promote and further the business of the Company. The Executive will
faithfully adhere to, execute and fulfill all policies established by the
Company's Board of Directors. The Executive also agrees to serve as a director
of the Company (without additional consideration other than provided by this
Agreement) until the Executive's successor is duly elected and qualified or
until the Executive's earlier resignation, removal or death.
 
The Executive hereby confirms that he is under no contractual commitments
inconsistent with his obligations set forth in this Agreement. The Executive
will not, during the term of Executive's employment hereunder, be engaged in any
other business activity pursued for gain, profit or other pecuniary advantage if
such activity materially interferes with the Executive's duties and
responsibilities hereunder. The foregoing limitations will not be construed to
prohibit the Executive from participating in reasonable charitable activities or
making personal investments in such form or manner as will neither require the
Executive's services in the operation or affairs of the companies or enterprises
in which such investments are made nor violate the terms of Section 4 hereof.
 The Executive may also serve as a board member on the boards of directors (or
managers) of other companies that the Company's Board of Directors and the
Executive mutually determine will not create a conflict with his duties
hereunder.

--------------------------------------------------------------------------------

2.    Compensation
 
(a)    Base Salary.  As compensation in full for all services to be rendered by
the Executive after the Start Date, the Company shall pay to the Executive an
annual base salary of $400,000 (pro rated for the fiscal year ending March 31
2014), less deductions and withholdings, which salary shall be payable on a
regular basis in accordance with the Company's standard payroll procedures but
not less than semi-monthly. Such base salary will be subject to annual review
and adjustment by the Company's Compensation Committee, but in no event shall
the salary for any subsequent year be less than the salary in effect for the
prior year.
 
(b)    Incentive Compensation.  During the Term, the Executive shall be entitled
to annual cash incentive compensation based upon achievement of such financial
milestones or business milestones, or both, as shall be established annually by
the Company's Compensation Committee, or the Committee of the Board charged with
establishing executive compensation, and, with respect to such annual
milestones, in consultation with the Executive.  The Executive's targeted annual
cash incentive compensation shall be a percentage (not less than 75%) of the
Executive's base salary for the fiscal year for which achievement of the
incentive compensation relates and, in the event the Executive exceeds such
financial or business milestones, such percentage will be adjusted upwards
proportionately, in accordance with the terms of the plan then in effect.  The
annual incentive compensation shall be payable within 15 days of the completion
of the audit of the financial statements for the related fiscal year.
 Notwithstanding the foregoing, for the fiscal year ending March 31, 2014,
Executive' cash incentive compensation shall be prorated for the 259 days from
the Start Date to the fiscal year end and shall pay Executive, at targeted
performance, cash incentive compensation equal to 259/365 multiplied by 75% of
his salary, or $212,877, and Executive shall be entitled to a minimum bonus of
$150,000 for such fiscal year, which minimum bonus shall be paid to the
Executive no later than December 31, 2013.
 
(c)            Participation in Benefit Plans.  While he is employed by the
Company, the Executive shall be eligible to participate in all Executive benefit
plans or programs (including vacation time) of the Company to the extent that
the Executive meets the requirements for each individual plan.  The Company
provides no assurance as to the adoption or continuance of any particular
Executive benefit plan or program, and the Executive's participation in any such
plan or program shall be subject to the provisions, rules and regulations
applicable thereto.  Notwithstanding the foregoing, Executive shall be entitled
to (i) an annual stipend of $18,000 to cover the costs of premiums for the
Executive's personal life and disability insurance policies and (ii) no less
than 20 days of paid vacation per year.
 
(d)            Expenses.  The Company will pay or reimburse the Executive for
all properly documented, reasonable and necessary out-of-pocket travel and
business expenses incurred by him in the performance of his duties under this
Agreement, subject to the Company's normal policies for expense verification.
2

--------------------------------------------------------------------------------

(e)            Issuance of Stock Option.  As of the close of business on the
Start Date, the Company shall grant to the Executive a non-qualified stock
option to purchase up to 700,000 shares of the Company's common stock pursuant
to the Company's 2006 Stock and Incentive Plan (the "Plan") at an exercise price
equal to the closing price of the Company's common stock on the Nasdaq Stock
Market on the Start Date.  Such option shall be vested and become exercisable
with respect to 233,334 shares on the first, second and third anniversaries of
the Start Date and any unvested portion of the option shall become fully vested
and exercisable upon a Change of Control (as defined in the Plan), shall expire
seven years from the Start Date, and shall have other terms and conditions set
forth in the Company's standard option agreement, except that the option shall
become fully vested and exercisable for a period of twelve months if Executive
is terminated pursuant to Section 7(d).
 
(f)            Stock Grant.  On the Start Date, the Company shall grant to the
Executive 300,000 shares of its common stock.
 
(h)            Legal Expenses.  The Company shall pay or reimburse the Executive
for all reasonable legal fees and administrative expenses related to the use and
engagement of legal counsel by the Executive in the course of preparing this
Agreement and any amendments thereto, subject to such reasonable substantiation
and documentation as may be specified by the Company.
 
3.    Confidential Information.  Except as permitted or directed by the
Company's Board of Directors, during the Term of his employment or at any time
thereafter, the Executive shall not divulge, furnish or make accessible to
anyone or use in any way (other than in the ordinary course of the business of
the Company) any confidential or secret knowledge or information of the Company
that the Executive has acquired or become acquainted with or will acquire or
become acquainted with prior to the termination of the Term of his employment by
the Company (including employment by the Company or any affiliated companies
prior to the date of this Agreement), whether developed by himself or by others,
concerning any trade secrets, confidential or secret designs, processes,
formulae, plans, devices or material (whether or not patented or patentable)
directly or indirectly useful in any aspect of the business of the Company, any
customer or supplier lists of the Company, any confidential or secret
development or research work of the Company, or any other confidential
information or secret aspects of the business of the Company.  The Executive
acknowledges that the above-described knowledge or information constitutes a
unique and valuable asset of the Company and represents a substantial investment
of time and expense by the Company, and that any disclosure or other use of such
knowledge or information other than for the sole benefit of the Company would be
wrongful and would cause irreparable harm to the Company.  Both during and after
the term of his employment, the Executive will refrain from any acts or
omissions that would reduce the value of such knowledge or information to the
Company.  The foregoing obligations of confidentiality shall not apply to any
knowledge or information that (a) is now published or which subsequently becomes
generally publicly known in the form in which it was obtained from the Company,
other than as a direct or indirect result of the breach of this Agreement by the
Executive, (b) is or becomes available to the Executive on a non-confidential
basis from a source which, to the Executive's knowledge, is not prohibited from
disclosing such information, (c) is required to be disclosed to enforce this
Agreement or (d) is required to be disclosed by applicable law or pursuant to
the valid order of a court of competent jurisdiction or an authorized government
agency.
3

--------------------------------------------------------------------------------

4.    Ventures.  If, during the term of his employment the Executive is engaged
in or associated with the planning or implementing of any project, program or
venture involving the Company and a third party or parties, all rights in such
project, program or venture shall belong to the Company.  Except as approved by
the Company's Board of Directors, the Executive shall not be entitled to any
interest in such project, program or venture or to any commission, finder's fee
or other compensation in connection therewith other than the compensation to be
paid to the Executive as provided in this Agreement.  The Executive shall have
no interest, direct or indirect, in any vendor or customer of the Company.
 
5.    Noncompetition Covenant.
 
(a)    Agreement Not to Compete.  During the Term of his employment with the
Company and for a period of one year after the termination of such employment
for any reason (whether such termination is with or without Cause, or whether
such termination is occasioned by the Executive or the Company), he shall not,
directly or indirectly:
 
(i)  engage in competition with the Company in the United States or in any
country in which the Company is conducting any Uroplasty Line of Business (as
defined below) as of the Executive's date of termination of employment in any
manner or capacity (whether as an officer, director, shareholder, owner,
partner, joint venturer or in a managerial capacity, or as an employee,
independent contractor, consultant or advisor or as a sales representative), in
any business that the Company is conducting during the Term of this Agreement,
which business shall include, without limitation, the development,
manufacturing, licensing, marketing or distribution of products or services for
the treatment of urinary or fecal voiding dysfunctions (the "Uroplasty Line of
Business"); or
 
(ii)  call upon or solicit any person who is at that time an employee of the
Company for the purpose or with the intent of enticing such employee away from
or out of the employment or former employment by the Company.
 
(b)    Limitation of Covenant.  Ownership by the Executive, as a passive
investment, of less than two percent of the outstanding shares of capital stock
of any corporation listed on a national securities exchange or publicly traded
on Nasdaq shall not constitute a breach of this Section 5.
 
(c)    Indirect Competition.  The Executive will not, directly or indirectly,
assist or encourage any other person in carrying out, directly or indirectly,
any activity that would be prohibited by the above provisions of this Section 5
if such activity were carried out by the Executive, either directly or
indirectly.  In particular the Executive agrees that he will not, directly or
indirectly, induce any employee of the Company to carry out, directly or
indirectly, any such activity.
 
(d)    Acknowledgment.  The Executive agrees that the restrictions and
agreements contained in this Section 5 are reasonable and necessary to protect
the legitimate interests of the Company and that any violation of this Section 5
will cause substantial and irreparable harm to the Company that would not be
quantifiable and for which no adequate remedy would exist at law and accordingly
injunctive relief shall be available for any violation of this Section 5.
 
(e)    Blue Pencil Doctrine.  If the duration or geographical extent of, or
business activities covered by, this Section 5 are in excess of what is valid
and enforceable under applicable law, then such provision shall be construed to
cover only that duration, geographical extent or activities that are valid and
enforceable.  The Executive acknowledges the uncertainty of the law in this
respect and expressly stipulates that this Agreement be given the construction
which renders its provisions valid and enforceable to the maximum extent (not
exceeding its express terms) possible under applicable law.
4

--------------------------------------------------------------------------------

(f)    Independently Enforceable.  All of the covenants in this Section 5 shall
be construed as an agreement independent of any other provision in this
Agreement, and the existence of any claim or cause of action of the Executive
against the Company, whether predicated on this Agreement or otherwise, shall
not constitute a defense to the enforcement by the Company of such covenants. It
is specifically agreed that the period of one (1) year following termination of
employment stated at the beginning of this Section 5, during which the
agreements and covenants of the Executive made in this Section 5 shall be
effective, shall be computed by excluding from such computation any time during
which the Executive is in violation of any provision of this Section 5.
 
6.    Patent and Related Matters.
 
(a)    Disclosure and Assignment.  The Executive will promptly disclose in
writing to the Company complete information concerning each and every invention,
discovery, improvement, device, design, apparatus, practice, process, method or
product, whether patentable or not, made, developed, perfected, devised,
conceived or first reduced to practice by the Executive, either solely or in
collaboration with others, during the term of this Agreement or within six
months thereafter, whether or not during regular working hours, relating either
directly or indirectly to the business, products, practices or techniques of the
Company ("Developments").  The Executive, to the extent that he has the legal
right to do so, hereby acknowledges that any and all of the Developments are the
property of the Company and hereby assigns and agrees to assign to the Company
any and all of the Executive's right, title and interest in and to any and all
of the Developments.  At the request of the Company, the Executive will confer
with the Company and its representatives for the purpose of disclosing all
Developments to the Company as the Company shall reasonably request during the
period ending six months after termination of the Executive's employment with
the Company.
 
(b)    Future Developments.  As to any Developments made by the Executive that
relate to the business, products or practices of the Company and that are first
conceived or reduced to practice during the term of this Agreement, but which
are claimed for any reason to belong to an entity or person other than the
Company, the Executive will promptly disclose the same in writing to the Company
and shall not disclose the same to others if the Company, within 20 days
thereafter, shall claim ownership of such Developments under the terms of this
Agreement.  If the Company makes no such claim, the Executive hereby
acknowledges that the Company has made no promise to receive and hold in
confidence any such information disclosed by the Executive.
 
(c)    Limitation on Sections 6(a) and 6(b).  The provisions of Section 6(a) and
6(b) shall not apply to any Development meeting the following conditions:
 
(i)            such Development was developed entirely on the Executive's own
time;
5

--------------------------------------------------------------------------------

(ii)           such Development was made without the use of any Company
equipment, supplies, facility or trade secret information;
 
(iii)          such Development does not relate (A) directly to the business of
the Company or (B) to the Company's actual or demonstrably anticipated research
or development; and
 
(iv)         such Development does not result from any work performed by the
Executive for the Company.
 
(d)    Assistance of the Executive.  Upon request and without further
compensation therefor, but at no expense to the Executive, the Executive will do
all lawful acts, including but not limited to, the execution of papers and
lawful oaths and the giving of testimony, that in the opinion of the Company,
may be necessary or desirable in obtaining, sustaining, reissuing, extending and
enforcing United States and foreign copyrights and Letters Patent, including but
not limited to, design patents, on the Developments, and for perfecting,
affirming and recording the Company's complete ownership and title thereto, and
to cooperate otherwise in all proceedings and matters relating thereto.
 
(e)    Records.  The Executive will keep complete, accurate and authentic
accounts, notes, data and records of the Developments in the manner and form as
reasonably requested by the Company.  Such accounts, notes, data and records
shall be the property of the Company, and, upon its request, the Executive will
promptly surrender same to it or, if not previously surrendered upon its request
or otherwise, the Executive will surrender the same, and all copies thereof, to
the Company upon the conclusion of his/her employment.
 
(f)    Obligations, Restrictions and Limitations.  The Executive understands
that the Company may enter into agreements or arrangements with agencies of the
United States Government, and that the Company may be subject to laws and
regulations which impose obligations, restrictions and limitations on it with
respect to inventions and patents which may be acquired by it or which may be
conceived or developed by Executives, consultants or other agents rendering
services to it.  The Executive shall be bound by all such obligations,
restrictions and limitations applicable to any such invention conceived or
developed by him/her while he/she is employed by the Company and shall take any
and all further action which may be required to discharge such obligations and
to comply with such restrictions and limitations.
 
(g)    Copyrightable Material.  All right, title and interest in all
copyrightable material that the Executive shall conceive or originate, either
individually or jointly with others, and which arise out of the performance of
this Agreement, will be the property of the Company and are by this Agreement
assigned to the Company along with ownership of any and all copyrights in the
copyrightable material.  Upon request and without further compensation therefor,
but at no expense to the Executive, the Executive shall execute all papers and
perform all other acts necessary to assist the Company to obtain and register
copyrights on such materials in any and all countries.  Where applicable, works
of authorship created by the Executive for the Company in performing his/her
responsibilities under this Agreement shall be considered "works made for hire,"
as defined in the U.S. Copyright Act.
6

--------------------------------------------------------------------------------

(h)    Know-How and Trade Secrets.  All know-how and trade secret information
conceived or originated by the Executive that arises out of the performance of
his obligations or responsibilities under this Agreement shall be the property
of the Company, and all rights therein are by this Agreement assigned to the
Company.
 
7.    Term: Termination, Rights on Termination.  The term of Executive's
employment under this Agreement shall begin on the Start Date and shall continue
through March 31, 2014 and, unless terminated earlier as provided herein, shall
continue thereafter on a year-to-year basis on the same terms and conditions
contained herein. As used herein, the word "Term" means (i) during the initial
period referred to in the preceding sentence, such initial period, and (ii)
during any one-year renewal pursuant to the terms hereof, such one-year period.
This Agreement and the Executive's employment may be terminated in any one of
the following ways:
 
(a)    Death. The Executive's death will immediately terminate this Agreement.
The Company will pay the Executive's estate any of Executive's accrued base
salary and any earned, but unpaid, incentive compensation (at the time otherwise
payable under this Agreement) through the date of termination, and any expenses
subject to reimbursement pursuant to Section 2(d) and not so reimbursed.
 
(b)    Disability. If, as a result of incapacity due to physical or mental
illness or injury, as reasonably determined by the Executive's physician, the
Executive is absent from the Executive's full-time duties hereunder for four (4)
consecutive months, then thirty (30) days after receiving written notice (which
notice may occur before or after the end of such four (4) month period, but
which will not be effective earlier than the last day of such four (4) month
period), the Company may terminate the Executive's employment hereunder;
provided that the Executive is unable to resume the Executive's full-time duties
at the conclusion of such notice period. The Company will pay the Executive any
of the Executive's accrued base salary and any earned, but unpaid, incentive
compensation (at the time otherwise payable under this Agreement) through the
date of termination, and any expenses subject to reimbursement pursuant to
Section 2(d) and not so reimbursed.
 
(c)    Cause. The Company may terminate this Agreement immediately upon written
notice to the Executive for Cause. For such purposes, "Cause" shall mean (i) the
Executive's willful, material and irreparable breach of this Agreement
(continuing for thirty (30) days after receipt of written notice of need to
cure, if curable); (ii) the Executive's gross negligence in the performance or
intentional nonperformance (continuing for thirty (30) days after receipt of
written notice of need to cure) of any of the Executive's material duties and
responsibilities under this Agreement; (iii) the Executive's willful dishonesty,
fraud or misconduct with respect to the business or affairs of the Company which
materially and adversely affects the operations or reputation of the Company; or
(iv) the Executive's conviction of a felony crime which materially and adversely
affects the operations or reputation of the Company. Upon any termination for
Cause above, the Executive will receive no severance compensation other than
base salary accrued through the date of termination and reimbursement of
expenses.
7

--------------------------------------------------------------------------------

(d)    Without Cause. At any time and upon thirty (30) days prior written
notice, either the Executive or the Company may terminate this Agreement and the
Executive's employment. If (i) the Company terminates the Executive's employment
without Cause during or at the end of any Term, (ii) this Agreement expires or
otherwise terminates at the end of a Term without renewal, (iii) the Executive
voluntarily terminates employment with the Company as a result of (A) the
Company's imposition of material and adverse changes, without the Executive's
consent, in the Executive's principal duties, responsibilities, status,
reporting relationship, title or authority, or the Company's assignment of
duties inconsistent with the Executive's position, (B) a material reduction in
the Executive's annual base salary or target annual incentive compensation
opportunity, (C) the Company moving its principal executive offices more than 50
miles from its current location without the Executive's consent, or (D) the
Company's material breach of this Agreement and, in the case of each of (iii)(A)
– (D), such condition remains uncured by the Company after receipt of thirty
(30) days prior written notice of the existence of such condition, or (iv)
within three months prior to or 24 months after a Change of Control (as defined
in Section 12(i) of the Plan) during the Term, the Executive's employment is
terminated pursuant to clause 7(d)(i) or (iii), the Executive will receive from
the Company any base salary accrued through the date of termination and
reimbursement of expenses. In addition, and conditioned on the Executive's
continuing compliance with the other provisions of this Agreement, including
Section 5 above:
 
(A) in the case of any termination pursuant to clauses (i) through (iii) of this
Section 7(d), the Company shall continue to provide Executive with all health
and welfare benefits at the same level of coverage and at the same cost of
premiums to the Executive as he was receiving immediately prior to his date of
termination of employment (including health, life, disability and dental
insurance benefits, if so provided) for a period of one year after the date of
termination, and in addition the Company shall pay the Executive, as severance
pay, an aggregate amount equal to 100% of Executive's annual base salary in
effect at the time of termination plus a pro rata portion (based on the number
of days of employment during that fiscal year) of the targeted incentive
compensation that would have been earned by Executive in the year of
termination, assuming for such purposes that the Company and Executive achieve
100% of the incentive compensation plan objectives for the full year; and
 
(B) in the case of any termination pursuant to clause (iv) of this Section 7(d),
the Company shall continue to provide Executive with all health and welfare
benefits at the same level of coverage and at the same cost of premiums to the
Executive as he was receiving immediately prior to his date of termination of
employment (including health, life, disability and dental insurance benefits, if
so provided) for a period of one year after the date of termination, and in
addition shall pay the Executive, as severance pay, an aggregate amount equal to
200% (two times) the sum of (x) Executive's annual base salary in effect at the
time of termination, plus (y) the targeted incentive compensation that would
have been earned by Executive in the year of termination assuming for such
purposes that the Company and Executive achieve 100% of the incentive
compensation plan objectives for the full year.
 
The severance payments will be subject to customary tax withholdings.
8

--------------------------------------------------------------------------------

The severance payments will be payable in equal monthly installments on the
first day of each month over the first year after the date of termination;
provided, however, that if the Company determines in its discretion that the
Executive is a "specified employee" (as defined in Section 409A(a)(2)(B)(i) of
the Internal Revenue Code of 1986, as amended (the "Code")) as of the date of
termination and that Section 409A of the Code applies with respect to a payment
to Executive pursuant to this Section 7(d), the severance payments will commence
on the six-month anniversary of the date of termination (or the date of
Executive's death, if earlier). The Company reserves the right to revise the
timing of any payments hereunder in order to comply with Section 409A of the
Code. As a condition to receiving the severance payments provided in this
Section 7(d), the Company may require the Executive to execute a full release
and waiver of all claims against the Company substantially similar to the form
attached hereto as Exhibit 1. If the Company requires such a release, the
Company will further delay the commencement of severance payments until the
period of rescission for the release has lapsed.
 
(e)    Surrender of Records and Property.  Upon termination of his employment
with the Company, the Executive shall deliver promptly to the Company all
records, manuals, books, blank forms, documents, letters, memoranda, notes,
notebooks, reports, data, tables, calculations or copies thereof that relate in
any way to the business, products, practices or techniques of the Company, and
all other property, trade secrets and confidential information of the Company,
including, but not limited to, all documents that in whole or in part contain
any trade secrets or confidential information of the Company, which in any of
these cases are in his possession or under his control.
 
8.    Excise Taxes.
 
(a)    For the period of the Term beginning on the Start Date and continuing
through December 31, 2014, if it is determined that any payments and benefits
provided under this Agreement and benefits provided to, or for the benefit of,
the Executive under any other Company plan or agreement (such payments or
benefits are collectively referred to as the "Payments") would be subject to any
tax under Section 4999 of the Internal Revenue Code of 1986, as amended (or a
successor provision) (such tax, together with any interest and penalties related
thereto are hereinafter collectively referred to as an "Excise Tax"), then the
Company shall promptly pay to Executive an additional payment ("Gross-Up
Payment") in an amount that would be necessary for Executive to retain, after
payment of all taxes and all interest and penalties with respect thereto
(including, without limitation, federal, state and local taxes and Excise Tax
imposed upon the Gross-Up Payment), an amount of the Gross-Up Payment equal to
one-half of the Excise Tax imposed upon the Payments.  The determination of the
amount of any Gross-Up Payment shall be made by a certified public accounting
firm selected jointly by the Company and Executive, the fees and expenses of
which shall be paid by the Company.  For the avoidance of doubt, this Section
8(a) shall be of no further force and effect as of January 1, 2015.
9

--------------------------------------------------------------------------------

(b)    For the period of the Term beginning January 1, 2015, notwithstanding
anything contained in this Agreement to the contrary, to the extent that the
Payments would be subject to the Excise Tax, the Payments shall be reduced (but
not below zero) if and to the extent necessary so that no Payment to be made or
benefit to be provided to Executive shall be subject to the Excise Tax (such
reduced amount is hereinafter referred to as the "Limited Payment Amount");
provided, however, that no such reduction under this Section 8 shall occur if
(i) the Limited Payment Amount (after subtracting the net amount of federal,
state and local taxes on such reduced Payments) is less than (ii) the net amount
of such Payments without reduction to the Limited Payment Amount (but after
subtracting the net amount of federal, state and local taxes on such unreduced
Payments and the amount of excise taxes to which the Executive would be subject
in respect of such unreduced Payments).  If the reduction to the Limited Payment
Amount described in the first part of the preceding sentence occurs, unless the
Executive shall have given prior written notice specifying a different order to
the Company to effectuate the foregoing, the Company shall reduce or eliminate
the Payments, by first reducing or eliminating the portion of the Payments which
are not payable in cash and then by reducing or eliminating cash payments, in
each case in reverse order beginning with payments or benefits which are to be
paid the farthest in time from the date of termination of employment.  Any
notice given by Executive pursuant to the preceding sentence shall take
precedence over the provisions of any other plan, arrangement or agreement
governing the Executive's rights and entitlements to any benefits or
compensation.
 
9.    Settlement of Disputes.
 
(a)    Arbitration.  Except as provided in Section 10(b), any claims or disputes
of any nature between the Company and the Executive arising from or related to
the performance, breach, termination, expiration, application or meaning of this
Agreement or any matter relating to the Executive's employment and the
termination of that employment by the Company shall be resolved exclusively by
arbitration in Minneapolis, Minnesota, in accordance with the applicable rules
of the American Arbitration Association.  In the event of submission of any
dispute to arbitration, each party shall, not later than 30 days prior to the
date set for hearing, provide to the other party and to the arbitrator(s) a copy
of all exhibits upon which the party intends to rely at the hearing and a list
of all persons each party intends to call at the hearing.  The fees of the
arbitrator(s) and other costs incurred by the Executive and the Company in
connection with such arbitration shall be paid by the party that is unsuccessful
in such arbitration.
 
The decision of the arbitrator(s) shall be final and binding upon both parties.
 Judgment of the award rendered by the arbitrator(s) may be entered in any court
of competent jurisdiction.
 
(b)    Resolution of Certain Claims—Injunctive Relief.  Section 9(a) shall have
no application to claims by the Company asserting a violation of Section 3, 4,
5, 6 or 7(e) or seeking to enforce, by injunction or otherwise, the terms of
Section 3, 4, 5, 6 or 7(e).  Such claims may be maintained by the Company in a
lawsuit subject to the terms of Section 9(c).  The Executive acknowledges that
it would be difficult to fully compensate the Company for damages resulting from
any breach by him of the provisions of this Agreement.  Accordingly, the
Executive agrees that, in addition to, but not to the exclusion of any other
available remedy, the Company shall have the right to enforce the provisions of
Sections 3, 4, 5, 6 or 7(e) by applying for and obtaining temporary and
permanent restraining orders or injunctions from a court of competent
jurisdiction without the necessity of filing a bond therefor, and without the
necessity of proving actual damages, and the Company shall be entitled to
recover from the Executive its reasonable attorneys' fees and costs in enforcing
the provisions of Sections 3, 4, 5, 6 or 7(e).
10

--------------------------------------------------------------------------------

(c)    Venue.  Any action at law, suit in equity or judicial proceeding arising
directly, indirectly, or otherwise in connection with, out of, related to or
from this Agreement, or any provision hereof, shall be litigated only in the
courts of the State of Minnesota, County of Hennepin.  The Executive and the
Company consent to the jurisdiction of such courts over the subject matter set
forth in Section 9(b).  The Executive waives any right the Executive may have to
transfer or change the venue of any litigation brought against the Executive by
the Company.
 
10.    Miscellaneous.
 
(a)    Entire Agreement.  This Agreement (including the exhibits, schedules and
other documents referred to herein) contains the entire understanding between
the parties hereto with respect to the subject matter hereof (other than any
equity award agreements or other incentive award agreements the Executive
becomes party to during the Term) and supersedes any prior understandings,
agreements or representations, written or oral, relating to the employment of
Executive after the Start Date.  For the avoidance of doubt, until the Start
Date the Executive shall continue to provide services to the Company under his
prior arrangement as Interim Chief Executive Officer and shall be entitled to
one-half of one-month's compensation under that arrangement for the month of
July.
 
(b)    Counterparts.  This Agreement may be executed in separate counterparts,
each of which will be an original and all of which taken together shall
constitute one and the same agreement, and any party hereto may execute this
Agreement by signing any such counterpart.
 
(c)    Severability.  Whenever possible, each provision of this Agreement shall
be interpreted in such a manner as to be effective and valid under applicable
law but if any provision of this Agreement is held to be invalid, illegal or
unenforceable under any applicable law or rule, the validity, legality and
enforceability of the other provision of this Agreement will not be affected or
impaired thereby.  In furtherance and not in limitation of the foregoing, should
the duration or geographical extent of, or business activities covered by, any
provision of this Agreement be in excess of that which is valid and enforceable
under applicable law, then such provision shall be construed to cover only that
duration, extent or activities which may validly and enforceably be covered.
 The Executive acknowledges the uncertainty of the law in this respect and
expressly stipulates that this Agreement be given the construction which renders
its provision valid and enforceable to the maximum extent (not exceeding its
express terms) possible under applicable law.
 
(d)    Successors and Assigns.  This Agreement shall be binding upon and inure
to the benefit of the parties hereto and their respective heirs, personal
representatives and, to the extent permitted by subsection (e), successors and
assigns.  The Company will require any successor of all or substantially all of
the business and/or assets of the Company to expressly assume and agree to
perform this Agreement in the same manner and to the same extent that the
Company would be required to perform it if no such succession had taken place.
 Failure by the Company to obtain such an assumption prior to the effectiveness
of any such succession will be a material breach of this Agreement.
11

--------------------------------------------------------------------------------

(e)    Assignability.  Neither this Agreement nor any right, remedy, obligation
or liability arising hereunder or by reason hereof shall be assignable
(including by operation of law) by either party without the prior written
consent of the other party to this Agreement, except that the Company may,
without the consent of the Executive, assign its rights and obligations under
this Agreement to any corporation, firm or other business entity with or into
which the Company may merge or consolidate, or to which the Company may sell or
transfer all or substantially all of its assets, or of which 50% or more of the
equity investment and of the voting control is owned, directly or indirectly,
by, or is under common ownership with, the Company.  After any such assignment
by the Company, the Company shall be discharged from all further liability
hereunder and such assignee shall thereafter be deemed to be the Company for the
purposes of all provisions of this Agreement including this Section 10.
 
(f)    Modification, Amendment, Waiver or Termination.  No provision of this
Agreement may be modified, amended, waived or terminated except by an instrument
in writing signed by the parties to this Agreement.  No course of dealing
between the parties will modify, amend, waive or terminate any provision of this
Agreement or any rights or obligations of any party under or by reason of this
Agreement.  No delay on the part of the Company in exercising any right
hereunder shall operate as a waiver of such right.  No waiver, express or
implied, by the Company of any right or any breach by the Executive shall
constitute a waiver of any other right or breach by the Executive.
 
(g)    Notices.  All notices, consents, requests, instructions, approvals or
other communications provided for herein shall be in writing and delivered by
personal delivery, overnight courier, mail, electronic facsimile or e-mail
addressed to the receiving party at the address set forth herein.  All such
communications shall be effective when received.
 
To the Company:
Uroplasty, Inc.
5420 Feltl Road
Minnetonka, Minnesota 55343
Attention: Chairman
 
 
To the Executive:
Robert C. Kill
3235 Graham Hill Road
Orono, MN  55356

 
Any party may change the address set forth above by notice to each other party
given as provided herein.
 
(h)    Headings.  The headings and any table of contents contained in this
Agreement are for reference purposes only and shall not in any way affect the
meaning or interpretation of this Agreement.
 
(i)    Governing Law.  ALL MATTERS RELATING TO THE INTERPRETATION, CONSTRUCTION,
VALIDITY AND ENFORCEMENT OF THIS AGREEMENT SHALL BE GOVERNED BY THE INTERNAL
LAWS OF THE STATE OF MINNESOTA, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW
PROVISIONS THEREOF.
 
(j)    Third-Party Benefit.  Nothing in this Agreement, express or implied, is
intended to confer upon any other person any rights, remedies, obligations or
liabilities of any nature whatsoever.
 
12

--------------------------------------------------------------------------------

 
(k)    Withholding Taxes.  The Company may withhold from any benefits payable
under this Agreement all federal, state, city or other taxes as shall be
required pursuant to any law or governmental regulation or ruling.
 
11.            Internal Revenue Code Section 409A.
 
 
 
(a) It is intended that this Agreement will comply with Section 409A of the Code
and any regulations and guidelines issued thereunder (collectively "Section
409A") to the extent this Agreement is subject thereto.  This Agreement shall be
interpreted on a basis consistent with such intent.

 

(b) If any payments or benefits provided to the Executive by the Company, either
per this Agreement or otherwise, are non-qualified deferred compensation subject
to, and not exempt from, Section 409A ("Subject Payments"), the following
provisions shall apply to such payments and/or benefits:

 

(i) For payments and benefits triggered by termination of employment, reference
to the Executive's "termination of employment" (and corollary terms) with the
Company shall be construed to refer to the Executive's "separation from service"
from the Company (with such phrase determined under Treas. Reg. Section
1.409A-1(h), as uniformly applied by the Company) in tandem with the termination
of his employment with the Company.

 

(ii) If the sixty (60) day period following the Executive's "separation from
service" begins in one calendar year and ends in a second calendar year (a
"Crossover 60-Day Period"), and if there are any Subject Payments due the
Executive that are:  (i) conditioned on the Executive signing and not revoking a
release of claims and (ii) otherwise due to be paid during the portion of the
Crossover 60-Day Period that falls within the first year, then such payments
will be delayed and paid in a lump sum during the portion of the Crossover
60-Day Period that falls within the second year.

 

(iii) The Executive's right to receive installment payments pursuant to this
Agreement shall be treated as a right to receive a series of separate and
distinct payments.

 

(iv) Whenever a payment under this Agreement specifies a payment period with
reference to a number of days, the actual date of payment within the specified
period shall be within the sole discretion of the Company.

 

(v) Notwithstanding any other provision of this Agreement to the contrary, in no
event shall any Subject Payment be subject to offset by any other amount unless
otherwise permitted by Section 409A.

13

--------------------------------------------------------------------------------

(vi) Notwithstanding anything herein to the contrary, in regard to Subject
Payments, the definition of Change in Control set forth herein shall not be
broader than the definition of "change in control event" as set forth under
Section 409A, and if a transaction or event does not otherwise fall within such
definition of "change of control event," it shall not be deemed a Change in
Control.

 

(vii) To the extent that any reimbursement or in-kind benefits are Subject
Payments: (x) the amount eligible for reimbursement or in-kind benefit in one
calendar year may not affect the amount eligible for reimbursement or in-kind
benefit in any other calendar year (except that a plan providing medical or
health benefits may impose a generally applicable limit on the amount that may
be reimbursed or paid), (y) the right to reimbursement or an in-kind benefit is
not subject to liquidation or exchange for another benefit, and (z) subject to
any shorter time periods provided herein, any such reimbursement of an expense
or in-kind benefit must be made on or before the last day of the calendar year
following the calendar year in which the expense was incurred.

 

(c) If an amendment of this Agreement is necessary in order for it to comply
with Section 409A, the Executive and the Company agree to negotiate in good
faith to amend this Agreement in a manner that preserves the original intent of
the parties to the extent reasonably possible.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
date set forth in the first paragraph.
 
 
UROPLASTY, INC.
 
 
By
/s/ JAMES P. STAUNER
 
 
James Stauner, Chairman
 
 
 
 
/s/ ROBERT C. KILL
 
Robert C. Kill

14

--------------------------------------------------------------------------------

EXHIBIT 1

CONFIDENTIAL RELEASE
 
WHEREAS, the employment of Robert C. Kill ("You") with Uroplasty, Inc., a
Minnesota corporation ("the Company") has terminated; and
 
WHEREAS, you and the Company executed the attached Employment Agreement
("Agreement") in which you agreed, among other things, to execute the below
release of claims following your termination of employment with the Company in
exchange for the severance payments and benefits described in Section 7 of the
Agreement;
 
NOW, THEREFORE, in consideration of the mutual promises contained in the
Agreement and this Exhibit 1, you agree as follows:
 
1.            RELEASE OF CLAIMS.  You intend to settle any and all claims that
you have or may have against the Company as a result of the Company's hiring
you, your employment with the Company and the termination of your employment
with the Company.  You agree that, in exchange for the Company's promises in
this Agreement, and in exchange for the consideration paid to you by the
Company, described above in Section 7 of the Agreement, you, on behalf of your
heirs, successors and assigns, hereby release and discharge the Company, its
predecessors,  investors, owners, successors, assigns, parents, affiliates,
subsidiaries, and related companies, and their officers, directors,
shareholders, agents, employees, and insurers (collectively the "Released
Parties") from all liability for damages and from all claims that you have or
may have against the Released Parties occurring through the date you sign this
Agreement.  You understand and agree that your release of claims in this
Agreement includes, but is not limited to, any claims you may have under:  Title
VII of the Federal Civil Rights Act of 1964, as amended; the Americans with
Disabilities Act; the Equal Pay Act; the Employee Retirement Income Security
Act; the Age Discrimination in Employment Act of 1967, as amended; the Older
Workers Benefit Protection Act; the Family and Medical Leave Act; the Worker
Adjustment and Retraining Notification Act of 1988; the Minnesota Human Rights
Act; Minn. Stat. § 176.82; Minn. Stat. § 181.81 et seq.; the Minnesota Equal Pay
for Equal Work Law.
 
You also agree and understand that you are giving up all other claims, whether
grounded in contract or tort theories, including but not limited to:  wrongful
discharge; breach of contract; tortious interference with contractual relations;
promissory estoppel; detrimental reliance; breach of the implied covenant of
good faith and fair dealing; breach of express or implied promise; breach of
manuals or other policies; breach of fiduciary duty; assault; battery; fraud;
false imprisonment; invasion of privacy; intentional or negligent
misrepresentation; defamation, including libel, slander, discharge defamation
and self-publication defamation; discharge in violation of public policy;
whistleblower; intentional or negligent infliction of emotional distress; or any
other theory, whether legal or equitable.  This release does not include claims
which may arise out of the breach of this Agreement.
 
You understand that nothing contained in this Release, including, but not
limited to, this Section 1, will be interpreted to prevent you from filing a
charge with the Equal Employment Opportunity Commission ("EEOC"), or other local
civil rights enforcement agency, or from participating in or cooperating with an
EEOC or other such agency investigation or proceeding.  However, you agree that
you are waiving the right to monetary damages or other individual legal or
equitable relief awarded as a result of any such proceeding.
15

--------------------------------------------------------------------------------

 
Nothing in this Section 1 is intended to or does:  (1) constitute an unlawful
release or waiver of any of your rights under any laws; (2) waive or release any
claim that arises after this Release is signed; (3) waive or release your right
to file an administrative charge with any local, state, or federal
administrative agency under applicable law, or participate in any agency
investigation, although you do waive and release your right to recover any
monetary or other damages under such applicable law, including but not limited
to compensatory damages, punitive damages, liquidated damages, or attorneys'
fees and costs; (4) waive or release your right to indemnity under Minnesota
Statutes Section 302A.521 or any successor provision, or under the Company's
Articles of Incorporation or bylaws, or any rights to insurance under policies
applicable to your service to the Company, whether or not such rights arise from
claims asserted before or after the date of this Release; (5) waive or release
your rights to the receipt of employee benefits which vested on or before the
date of this Release; or (6) waive or release your right to receive severance
benefits under Section 7 of the Agreement; (7) waive or release your existing
rights as an equity holder under any operating agreement, stockholders'
agreement or similar agreement of the Company and any vested rights under any
equity compensation plans, agreements or arrangements sponsored or maintained by
the Company; or (8) prevent or interfere with your right to provide truthful
testimony, if under subpoena or court order to do so, or respond as otherwise
provided by law.
 
2.            TIME TO ACCEPT.  You will have twenty-one (21) days from [date
given to Executive ], to consider whether to sign it.  Changes to this Exhibit
1, whether material or immaterial, will not restart the 21-day consideration
period.  During this time, the Company advises you to consult with an attorney
of your choice.  To receive the consideration described in Section 7 of the
Agreement, you must sign this Exhibit 1 and return the signed original to:
 [fill in].
 
3.            RIGHT TO REVOKE AND RESCIND.  You are hereby informed of your
right to revoke your release of claims, insofar as it extends to potential
claims under the Age Discrimination in Employment Act, by informing the Company
of your intent to do so within seven (7) calendar days following your signing of
this Exhibit 1.  You are also informed of your right to rescind your release of
claims, insofar as it extends to potential claims under the Minnesota Human
Rights Act, by delivering a written rescission to the Company within fifteen
(15) calendar days after your signing of this Exhibit 1.  These rescission and
revocation periods will run concurrently.  You understand that any such
revocation or rescission must be made in writing and delivered by hand or by
certified mail, return receipt requested, postmarked on or before the last day
within the applicable revocation period to:
 
[fill in]
 
If you exercise your right to revoke or rescind any portion of your release of
claims, the Company may, at its option, either nullify the Agreement and this
Exhibit 1 in their entirety, or keep them in effect in all respects other than
as to that portion of your release of claims that you have revoked or rescinded
(except that your employment ended on the Separation Date).  You agree and
understand that if the Company chooses to nullify the Agreement and Exhibit 1 in
its entirety, the Company will have no obligations under the Agreement and this
Exhibit 1.
16

--------------------------------------------------------------------------------

4.            NO RECOGNITION OF WRONGDOING.  The signing of this Exhibit 1 and
payment of the consideration described in the attached Agreement do not
represent any admission of wrongdoing or violation of any statute, agreement, or
common law by the Company.  You represent that, as of the date you sign this
Exhibit 1, you are not aware of any violations of federal or state law or
regulation or the Company policy, and that you are not aware of any facts which
would constitute a violation of any federal or state law or regulation or the
Company policy.  You further represent and warrant that you have not violated
any federal or state law, statute, regulation, or ordinance.  In agreeing to
this provision, the Company has relied on the representations by you in this
Section 4.  These representations are a material term of this Exhibit 1.
 
5.            CONTROLLING LAW.  This Exhibit 1 shall be governed by and
interpreted in accordance with the laws of the State of Minnesota.  To the
extent any clause or provision of this Exhibit 1 shall be determined to be
invalid and/or unenforceable, such a clause or provision shall be deleted and
the validity and enforceability of the remainder of this Exhibit 1 shall be
unaffected.
 
6.            VENUE.  Any action between you and the Company relating to your
employment or termination of employment with the Company, including, without
limitation, actions relating to or arising under the Agreement and/or this
Exhibit 1, shall be filed and adjudicated exclusively in the state and federal
courts of the State of Minnesota, and you and the Company hereby consent to the
jurisdiction of such courts for any such action and further waive any objection
to the convenience of the forum or venue.
 
7.            EMPLOYEE REPRESENTATION.  You agree and acknowledge that you have
received and read this Exhibit 1, that its provisions are understandable to you,
and that you fully appreciate and understand the meaning of the terms of this
Exhibit 1 and their effect.  You agree that no promise or inducement has been
offered except as set forth in this Exhibit 1, and that you are signing this
Exhibit 1 without reliance upon any statement or representation by the Company
or any representative or agent of the Company. You agree and acknowledge that
you have been provided with a reasonable and sufficient period of twenty-one
(21) days within which to consider whether or not to accept this Exhibit 1, and
you are hereby advised to consult with an attorney for advice prior to signing,
which advice you have taken.  You acknowledge and agree that you have entered
into this Exhibit 1 freely and voluntarily.
 
Dated: 
 
, 20
 
 
               
 
 
 
 
 
Robert C. Kill

 
 
17

--------------------------------------------------------------------------------